Vifor Pharma is a world leader in the discovery, development, manufacturing and marketing of pharmaceutical products for the treatment of iron deficiency. The company also offers a diversified portfolio of prescription medicines as well as non-prescription medicines. The Group also has a focus on the management of conditions in nephrology, cardiology and rare diseases.
Vifor Pharma's operational headquarters are in Zurich, Switzerland, and the company has an increasingly global presence and a broad network of affiliates and partners around the world.
1927
Served areaWorldwide
Headcount2,600
HeadquartersRechenstrasse 37, 9014 St. Gallen – Switzerland
65,000,000
IPOSept. 21, 2020
Stock exchange(s)SIX Swiss Exchange